Press releases
- Innoviva to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
- Innoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company Progress
- Innoviva to Participate in the BofA Securities Health Care Conference
- Innoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024
Key statistics
On Wednesday, Innoviva Inc (HVE:FRA) closed at 15.10, -1.95% below its 52-week high of 15.40, set on Jan 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 15.20 |
---|---|
High | 15.20 |
Low | 15.10 |
Bid | 15.10 |
Offer | 15.20 |
Previous close | 15.30 |
Average volume | 17.78 |
---|---|
Shares outstanding | 62.44m |
Free float | 61.86m |
P/E (TTM) | 7.41 |
Market cap | 1.03bn USD |
EPS (TTM) | 2.23 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 20:49 BST.
More ▼